News Feb. 05, 2021 Hydronephrosis and bladder cancer Retrospective research does not support an increased risk of upper tract urothelial carcinoma (UTUC) in patients receiving preoperative ureteral stenting for hydronephrosis requiring drainage prior to cystectomy. Feb. 05, 2021 Ureteral injury malpractice compensation highest in cases of patient-perceived delays, inadequate workup and failure of supervision Multiple studies suggest that iatrogenic ureteral injuries, while uncommon, make up a disproportionate number of litigation claims. Gynecology and urology are the specialties most commonly named. Feb. 05, 2021 High-risk nonmuscle invasive bladder cancer In a phase III clinical trial, 53% of patients with nonmuscle invasive bladder cancer (NMIBC) in the carcinoma in situ cohort had a complete response within three months of treatment. Nov. 20, 2020 COVID-19 adjustments impact Urology Residency training Boyd R. Viers, M.D., associate program director of the Urology Residency program at Mayo Clinic in Rochester, Minnesota, discusses pandemic-related changes in the program. Nov. 20, 2020 Men's Health moves many operative procedures into the office Mayo Clinic's Men's Health specialists now perform testicular sperm extraction, circumcision, scrotoplasty, orchiopexy, hydrocelectomy, and spermatocelectomy or epididymal cyst excision and epididymectomy in-office, wit[...] Nov. 20, 2020 Therapeutic sequencing improves outcomes for patients with progressive mCRPC Researchers investigated the long-term oncologic outcomes of three chemotherapy regimens in patients who had previously experienced disease progression after treatment with a novel androgen receptor inhibitor. Sept. 15, 2020 New research indicates maintenance bacillus Calmette-Guerin is not cost-effective for all patients with intermediate- and high-risk nonmuscle invasive bladder cancer New research supports prioritizing bacillus Calmette-Guerin (BCG) for induction therapy during shortages and reserving maintenance BCG for patients at the highest risk of progression. Sept. 15, 2020 Standardized postoperative opioid prescribing significantly reduces use following urologic surgery Prescribing patterns four months after guideline implementation were reduced to a median quantity of 100 OME (roughly 13 5 mg oxycodone tablets) compared with 150 OME before implementation. Sept. 15, 2020 Integrating telemedicine into the Mayo Clinic Urology practice to expand options for patients The COVID-19 pandemic provided opportunities to explore telemedicine consults with adult and pediatric urology patients. Feb. 22, 2020 Percutaneous biopsy of suspicious upper tract lesions a safe diagnostic strategy A retrospective review of patients who received percutaneous image-guided core-needle biopsy for diagnosis of upper tact urothelial carcinoma supports that the process is safe and well tolerated by those patients. Feb. 22, 2020 Mayo Clinic's approach to Peyronie's disease: Nonsurgical interventions Mayo specialists consider three key points when determining optimal treatments for patients with Peyronie's disease: baseline erectile function, duration of symptoms and level of invasiveness the patient will consider. Feb. 22, 2020 Optimal sequencing of commonly used medications for treatment of metastatic castration-resistant prostate cancer Research supports the use of docetaxel before enzalutamide or abiraterone as the primary first line therapy for metastatic castration-resistant prostate cancer. Dec. 10, 2019 Scientists find autoimmune disease related to testicular cancer Scientists urge screening for paraneoplastic encephalitis autoimmune disease in patients with testicular cancer: Mayo Clinic Forefront cancer magazine. Nov. 05, 2019 Pediatric rhabdomyosarcoma: Research and new treatment options A new trial of adjuvant surgical treatment with hyperthermic intraperitoneal chemotherapy (HIPEC) specifically addresses pediatric patients with relapsed intra-abdominal and pelvic rhabdomyosarcoma. Nov. 05, 2019 Adjuvant radiation for patients with positive margins after prostatectomy decreases local recurrence; no difference in overall survival Research indicates adjuvant radiation for patients with positive surgical margins after prostatectomy decreases local recurrence with no difference in overall survival. Nov. 05, 2019 Ultrasound-guided transperineal prostate biopsy Mayo Clinic specialists perform transperineal biopsy, which helps to accurately diagnose prostate cancer in patients with lesions or past complications and limits the infectious complications associated with transrectal[...] Aug. 27, 2019 Artificial urinary sphincter placement: Innovations and practices Mayo Clinic's minimal-touch protocol for artificial urinary sphincter placement minimizes perineal and abdominal skin exposure to decrease the rate of device infection. Aug. 27, 2019 Idiopathic chronic scrotal content pain: Q and A with Matt Ziegelmann, M.D. There are no standardized guidelines for evaluation and management of chronic scrotal content pain, but a consistent algorithm for evaluation and management can improve patients' quality of life. Aug. 27, 2019 New analysis shows radical prostatectomy to be cost-effective management of prostate cancer A cost-effectiveness study indicates that the ProtecT trial actually supports the upfront treatment of more-aggressive prostate cancers and the surveillance of less aggressive prostate cancers. July 15, 2019 Study shows advantages for stress urinary incontinence surgery ROCHESTER, Minn. ???-- One of the most commonly performed surgeries to treat stress urinary incontinence in women may have better long-term results than another common surgical technique, according to a study led by Mayo C[...] June 21, 2019 Pushing the envelope of robotic urologic surgery in children A single-port robotic system offers a safe, efficacious approach for minimally invasive surgeries, including pyeloplasty and appendicovesicostomy, in pediatric patients. June 21, 2019 Redefining the male urethral stricture treatment paradigm With Mayo Clinic's outpatient same-day ambulatory surgery approach, 95% of men treated for urethral stricture disease report a high level of patient satisfaction, with no difference in reconstructive outcomes. June 21, 2019 New data indicate percutaneous ablation may be an appropriate option for certain patients with renal masses A review of patients treated with partial nephrectomy, percutaneous radiofrequency ablation or percutaneous cryoablation for small renal masses found no clinical or statistical difference in five-year outcomes. May 09, 2019 A novel risk score may help urologists determine which patients with kidney stones require urgent intervention Researchers identified four significant predictors of infection to create a novel risk score that may help confirm which patients require urgent decompression via ureteral stent or nephrostomy tube placement. April 23, 2019 Mayo Clinic offers comprehensive care for women with pelvic floor disorders such as pelvic organ prolapse and urinary incontinence Mayo Clinic's unique, multidisciplinary approach to managing sensitive female pelvic floor disorders allows for individualized decision-making and broad access to a multitude of treatment options. April 23, 2019 Choice of intraoperative irrigation matters for penile implants: Povidone-iodine leads to a ninefold increase in the likelihood of developing an infection A switch from use of undiluted povidone-iodine to vancomycin-gentamicin for intraoperative irrigation reduced postoperative prosthesis infections by a factor of nine. Feb. 20, 2019 Mayo Clinic experience with da Vinci SP single-port robot-assisted radical prostatectomy Mayo specialists have performed more than 40 prostatectomies using the da Vinci SP single-port robot-assisted surgical system. They report unique benefits and favorable outcomes. Feb. 19, 2019 Boyd R. Viers, M.D., specializes in reconstructive genitourinary surgeries Dr. Viers specializes in advanced urinary reconstruction for radiation, trauma and iatrogenic urinary tract injury, and management of urinary obstructions including male urethral stricture disease, ureteral stricture an[...] Feb. 19, 2019 Top-of-the-line treatment for Wilms' tumor Mayo Clinic's Fertility Preservation Program, 3D modeling, minimally invasive surgery techniques and proton beam therapy improve survival rates for children with Wilms' tumor. Feb. 19, 2019 New studies of renal masses may assist in patient counseling Study findings expand providers' abilities to better educate patients with small renal masses and provide context for management strategies, enabling more-informed decisions about treatment options. Dec. 22, 2018 Variation in postoperative opioid prescribing provides motivation for a more standardized approach A task force focused on adult patients without a history of chronic opioid use undergoing urologic surgery recommends nonnarcotic pain regimens as first line treatment and maximum recommended quantities of opioids based[...] Dec. 21, 2018 Beating the beast: Mayo Clinic's pediatric urologists and their sarcoma team's mission to cure rhabdomyosarcoma Mayo pediatric radiologists construct 3D, color-coded models of the tumor and surrounding structures to assess the best potential therapies for each child and assist the surgical team with preoperative planning and refe[...] Dec. 21, 2018 Minimally invasive focal therapies for prostate cancer Focal therapy treats only the area with the most aggressive tumor, while leaving the rest of the prostate and its surrounding structures alone. Available options include cryoablation, focal laser ablation and high-frequ[...] Dec. 20, 2018 Brian J. Linder, M.D., female pelvic medicine and reconstructive surgery specialist, joins Mayo Clinic Urology Brian J. Linder, M.D., a specialist in the management of overactive bladder, including advanced treatment options such as bladder Botox injection, sacral neuromodulation and noninvasive percutaneous tibial nerve stimula[...] Medical Professionals Urology News